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Background: Children with cyclic vomiting syndrome (CVS) have a high degree of maternal inheritance of
functional gastrointestinal and neurological disorders. CVS in children is also associated with an increased
prevalence of mitochondrial DNA single-nucleotide polymorphisms (mtDNA SNPs) 16519 T and 3010A. Preliminary
data suggests that age of onset of symptoms (pediatric vs. adult) may be a determinant of the presence of such
mtDNA SNP’s. We sought to examine the degree of maternal inheritance pattern of functional disorders and the
prevalence of mtDNA SNP’s16519T and 3010A in adults with CVS and correlate this with age of onset of disease.
Methods: A Quantitative Pedigree Analysis (QPA) was performed in 195 of a total of 216 patients and all were
genotyped using Restriction Fragment Length Polymorphism (RFLP) or sequencing.
Results: Adults with CVS had a higher degree of probable maternal inheritance (PMI) of functional disorders than
controls (12% vs. 1%, p < 0.001). However, the prevalence of mitochondrial SNP’s 16519 T, 3010A and the AT
genotype were similar in Haplogroup H CVS patients compared to historical controls. There was no correlation
between age of onset of disease and prevalence of these mtDNA SNP’s.
Conclusions: A subset of adults with CVS has a significantly higher degree of maternal inheritance pattern of
functional disorders than controls. There was no association with mtDNA SNP’s 16519 T and 3010A as seen in
children and future studies sequencing the entire mitochondrial and nuclear genome to identify potential causes
for this maternal inheritance pattern in adults are warranted.
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Cyclic vomiting syndrome (CVS) is a chronic disorder
characterized by episodic nausea and vomiting and is
diagnosed using Rome criteria [1]. Subsets of CVS include
CVS plus and catamenial CVS. CVS plus is defined by
the presence of at least two neuromuscular disorders in
association with CVS [2]. CVS can sometimes occur in
association with the menstrual cycle and this is referred
to as catamenial CVS [3]. The pathophysiology of CVS is
not known but preliminary reports in children suggest
that genetic factors play an important role. Extensive* Correspondence: tvenkate@mcw.edu
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article, unless otherwise stated.pedigree analysis of children with CVS has revealed a
clustering of functional disorders in matrilineal relatives
[4,5]. There is a lack of similar data on matrilineal inherit-
ance patterns in adults with CVS. Further, analysis of the
mitochondrial genome in children has shown an increased
frequency of two mitochondrial DNA polymorphisms
16519 T and 3010A, which together confer 17-fold higher
odds of having CVS in comparison to controls [6]. The
16519 T polymorphism alone was associated with 6-fold
higher odds of CVS [6]. Experts consider CVS as part
of a migraine diathesis and mitochondrial single-nucleotide
polymorphisms (SNP’s) have been associated with mi-
graines as well [7].
Preliminary data by Boles et al. also suggests that
CVS is genetically distinct in those with onset oftral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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(adult–onset). A previous study showed that the associ-
ation between the 16519 T and 3010A polymorphisms
(the AT genotype) reported in children was absent in
adults, and it was speculated that the pathophysiology of
CVS may differ based on the age of onset of symptoms.
This same study also found that 56% of adults with CVS
had high Karolinska Scales of Personality (KSP) scores
which are both sensitive and specific for mitochondrial
dysfunction; findings not reconciled by the same study [8].
And so while there is some thought that CVS is genetic-
ally distinct based on onset of disease, the association with
migraine, high KSP scores in adult-onset CVS which are
specific and sensitive for mitochondrial dysfunction and
similar response to treatment suggests otherwise and
underscores the need for further analysis [9,10].
CVS remains a clinical challenge given the absence of
a biochemical marker and indeed the validity of this
diagnosis is questioned by some. Thus it is imperative that
we find surrogate markers for this disease; the presence of
a biological marker would enable physicians to diagnose
patients with a simple blood test and avoid expensive
investigations to exclude various other disorders. This
study is also relevant in the treatment of this disorder.
CVS is currently treated with tricyclic antidepressants and
mitochondrial supplements such as coenzyme Q 10 and
L-carnitine. Small trials and anecdotal data showed that
high doses of co-enzyme Q10, riboflavin and L-carnitine
have potential efficacy in CVS [11]. Identification of
mitochondrial heteroplasmies may allow us to develop
therapies towards mitochondrial dysfunction to treat
this and other related disorders.
We thus sought to perform a Quantitative Pedigree Ana-
lysis (QPA) using a standard questionnaire and estimate
the matrilineal inheritance pattern of various functional
disorders in adults with CVS. We also sought to identify
the frequency of mtDNA SNP’s, 16519 T and 3010A in
adults and determine if there are any significant associa-
tions with inheritance patterns and age of onset of disease.
Methods
Patients who met Rome III criteria for CVS were re-
cruited through the CVS Clinic at the Medical College
of Wisconsin. Other potential subjects were also recruited
through the Cyclic Vomiting Syndrome Association
(CVSA) website and message board. All subjects not
seen at the Medical College of Wisconsin (MCW) were
invited to contact the principal investigator’s office at
MCW in person, by e-mail or postal mail in order to
participate, and only those who met Rome III criteria
for CVS were included. Extensive clinical data was
collected using the standard questionnaire employed by
the CVS clinic at MCW and saliva samples were
collected in person or mailed in by the subject. TheInstitutional Review Boards at the Medical College of
Wisconsin, University of North Carolina (UNC) and the
Children’s Hospital of LA (CHLA) all approved the study.
Informed consent was obtained from all subjects and a
legal guardian when applicable. All subjects were > 18 years
of age at the time of the study.
Saliva was collected directly by the CVS probands using
a commercially available kit (Oragene, DNA Genotek Inc.,
Ottawa, Ontario) and then mailed to Children’s Hospital
Los Angeles (CHLA) where genetic analysis was performed.
The presence or absence of the 7028C polymorphism that
defines haplogroup H was determined in subjects either by
cyclosequencing or by RFLP following AluI digestion, as
per our routine practice. Both methods were used but
sequencing was used during the latter part of the study as
this was more readily available and less expensive than
RFLP. These methods were extensively cross-validated in
RB’s laboratory. All SNP’s, including all sequence variation
in the CVS subjects and any SNP’s identified were corre-
lated with the extensive clinical data obtained.
A detailed pedigree analysis was performed using a
standard scripted questionnaire (see Additional file 1). The
number of functional conditions per matrilineal relative
and patrilineal relative were calculated and the maternal
ratio and maternal inheritance ratio were calculated using
a previously published tool called Quantitative Pedigree
Analysis (QPA) which is used to assesses patterns of
inheritance [12]. A patient had a probable maternal inher-
itance (PMI) pattern if the maternal ratio was ≥1.75 and
the maternal inheritance ratio (MIR) is ≥ 3 where the MIR
is calculated by dividing the maternal and paternal ratios.
The inheritance pattern was defined as being indetermin-
ate (Ind) if the maternal ratio was 1.5 - <1.75 and/or the
MIR was 2 - <3, and as probable non-maternal inheritance
(PNMI) if either the maternal ratio was <1.5 and/or the
MIR is < 2. If the patient had cognitive impairment one or
both parents/caregivers were asked to provide the infor-
mation on the patient’s behalf.
Quantitative Pedigree Analysis was performed in 195/
216 patients with cyclic vomiting syndrome who were
genotyped and 102 healthy controls. Healthy controls
were recruited through mass electronic mail among the
faculty, staff and students at the University of North
Carolina (UNC), as well as through the UNC Center for
Functional GI and Motility Disorder registry of study
participants, and the International Foundation of Func-
tional Gastrointestinal Disorders website.
Our study group was characterized based on the onset
of symptoms; pediatric-onset CVS was defined by onset
of stereotypical vomiting episodes at <12 years of age,
adolescent-onset CVS if episodes began between 12
and 18 years of age, and adult-onset CVS if episodes
began ≥18 years of age. Adolescent onset CVS patient
were excluded from the analysis as they likely represent
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ical, emotional and cognitive maturity during this period.
Statistical analysis
Continuous variables were summarized using median and
inter-quartile ranges, and between-group comparison was
done using the Wilcoxon-Mann–Whitney test for two
groups, and Kruskal-Wallis test for three or more groups.
Categorical variables were summarized using proportions,
and comparisons were done using Fisher’s exact test for
binary and nominal outcomes, and proportional odds like-
lihood ratio test for ordered outcomes. A p-value of less
than 0.05 was considered significant for our analysis. The
prevalence of a genotype between CVS subgroups and
controls was compared and odds ratios with 95% CI was
reported. The type I error rate was controlled at 5% using
a single step multiple testing adjustment based on the
multivariate normal distribution in the context of a logis-
tic regression model. Data was analyzed using R 2.13.1.
Results
Study subjects
Our study population consisted of 216 adults with
CVS; 16% (35) had pediatric-onset CVS, 14% (30) had
adolescent-onset CVS and 70% (151) had adult-onset
CVS. Table 1 depicts the demographics and baseline
characteristics of patients with CVS based on age of
onset. The majority of patients from all three groups
were Caucasian and from the United States. The median
age of patients in these 3 groups were 26, 22 and 39 years,
respectively; adult-onset CVS patients were likely to be
older at the time of study (p value <0.001). Adult-onset
patients were also less likely to be female (62% vs. 86%
and 80%, p = 0.008) and have a lower incidence of neuro-
cognitive defects (CVS+) (0% vs. 12% and 7%, p = 0.001)
when compared to pediatric onset CVS. Most patients
had a personal and family history of migraine and the
three groups did not differ with regards to severity of
disease, disability, use of any prophylactic medication
for CVS, or response to standard therapy. A significant
proportion of patients (28%) had undergone unnecessary
surgery for CVS symptoms.
Control subjects
A total of 102 control subjects were recruited from
UNC for comparison of quantitative pedigree analysis.
The median age of controls was 38 (26–53) with 84% (119)
females (Table 2). They were significantly older (p = 0.01)
and more likely to female (<0.001) than CVS patients.
Previously published historical controls (n = 231) were
used for comparing the prevalence of genotypes in CVS
subgroups. These controls consisted of normal subjects
from different geographical locations (North America,
Europe, Finland and Italy) but were all Haplogroup H.To reduce potential bias, samples ascertained due to any
illness or symptoms, those from self-selected groups
(commercial heritage testing), and from small remote
islands and/or geographically isolated populations (Iceland
and Sardinia) were excluded [7]. Data on age and sex were
not collected in this control population.
Quantitative Pedigree Analysis and maternal inheritance
patterns of functional disorders in patients with CVS
and controls
The number of functional, neurological and endocrine
conditions in both first- and second-degree relatives was
determined and the maternal ratio, paternal ratio, and
maternal inheritance ratio were calculated using estab-
lished criteria. The pattern of inheritance (PMI, IND or
PNMI) in each individual was determined. Pedigree
analysis was also performed in a control population
consisting of 102 healthy adults. Table 2 demonstrates
the inheritance patterns in adults with CVS versus con-
trols. Adults with CVS were more likely to have a maternal
inheritance pattern of functional disorders in comparison
to controls (13% vs 1%, p < 0.001, Figure 1). CVS patients
also had a higher maternal ratio (1.0 vs 0.5, p <0.001) and a
higher MIR (2.2 vs 1.5, p = 0.009). Though controls were
older (median age 38.5 vs 33) and more likely to be female
(84% vs 69%) when compared to CVS patients, the differ-
ences in maternal ratio and MIR were not affected when
adjusting for age and gender via regression (Table 2).
Sub-group analysis of inheritance patterns based on
onset of disease showed that pediatric-onset CVS patients
were more likely to have a maternal inheritance pattern of
functional symptomatology compared to adult-onset CVS
patients. (25% vs 10%, p = 0.04) The inheritance patterns
were also examined by genotype, AT versus non-AT .The
maternal ratio, paternal ratio and maternal inheritance
ratios were similar in both AT and non-AT subgroups
(Table 3). The median MIR in the AT subgroup was
higher at 2.58 versus 2.0 in the non-AT group but did
not reach statistical significance. Nineteen % (3) of the
AT subgroup had a probable maternal inheritance
(PMI) pattern of functional symptomatology compared
to 13% (21) in the non-AT group, but this also did not
reach statistical significance.
The inheritance patterns were then examined based
on genotype (GT, AT, AC and GC) and no correlation was
detected between the patterns of inheritance as deter-
mined by QPA for each genotype (Table 4).
Mitochondrial DNA polymorphisms in CVS and controls
Of 216 adults who were genotyped, 16519 T alone was
present in 38% (81), 3010A in 25% (53) and both 16519 T
and 3010A in 8% (18). Of these, 33% (71) were Haplogroup
H, identified by the presence of the 7028C polymorphism
Of these 71 patients, 34% (24) had 16519 T, 31% (22) had
Table 1 Baseline characteristics of CVS patients based on time of onset of symptoms
Variables Available N Pediatric N-35 Adolescent N-30 Adults N-151 P-value
Age (Years) 216 26 22 39 <0.001┼**
Gender 216 0.006¥*
Male 14% (5) 20% (6) 38% (58)
Female 86% (30) 80% (24) 62% (93)
Race 196 0.293¥
White 100% 89% (25) 96% (129)
Black (33) 0% (0) 0% (0)
Hispanic 0% (0) 7% (2) 3% (4)
Other 0% (0) 4% (1) 1% (2)
Hispanic Other
Geographical Location 189 0.024¥*
Canada 4% (1) 0% (0) 0% (0)
Midwest 56% (15) 76% (22) 74% (98)
Northeast 22% (6) 3% (1) 4% (5)
South 7% (2) 7% (2) 13% (17)
United Kingdom 4% (1) 0% (0) 1% (1)
West 7% (2) 14% (4) 9% (12)
Type of CVS 181 0.001¥*
CVS Plus 12% (3) 7% (2) 0% (0)
Classical CVS 76% (19) 76% (22) 93% (118)
Catamenial CVS 12% (3) 17% (5) 7% (9)
Personal history of migraine 213 0.819¥
No 58% (19) 57% (17) 62% (93)
Yes 42% (14) 43% (13) 38% (57)
Family history of migraine 180 0.019¥*
No 48% (12) 36% (10) 63% (80)
Yes 52% (13) 64% (18) 37% (47)
Emergency room/urgent care visits/year 192 2 4.5 4 0.411┼
Hospital Admissions/year 140 1 1 2 0.729┼
Surgery related to CVS 182 0.715¥
No 78% (21) 68% (19) 72% (91)
Yes 22% (6) 32% (9) 28% (36)
Disability 180 0.421¥
No 89% (24) 89% (25) 80%
Yes 11% (3) 11% (3) (100) 20% (25)
Prophylactic medications 177 0.255¥
No 4% (1) 12% (3) 4% (5)
Yes 96% (26) 88% (23) 96% (119)
Response to therapy 105 0.613^
None 7% (1) 24% (4) 20% (15)
Partial 29% (4) 24% (4) 26% (19)
Complete 64% (9) 52% (9) 54% (40)
Median values represented for continuous variables. Numbers after percent’s are frequencies. Tests used: ┼Kruskal-Wallis test; ¥Fisher’s exact test; ^Proportional
odds likelihood ratio test.
*Indicates a P value <0.05.
**Indicates a P value < 0.001.
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Table 3 Inheritance patterns for AT vs non-AT genotype
Quantitative
pedigree analysis
Non-AT (N = 198) AT (N =18) P-value
Maternal Ratio 1 0.835 0.9231
Paternal Ratio 0.43 0.39 0.5651
Matrilineal Inheritance Ratio 2.04 2.58 0.4331
Inheritance pattern 0.9842
PNMI 80% (143) 81% (13)
Ind 8% (15) 0% (0)
PMI 12% (21) 19% (3)
Median values represented for continuous variables.
Numbers after percents are frequencies.
Tests used: 1Wilcoxon test; 2Proportional odds likelihood ratio test.
Table 2 Baseline characteristics and inheritance ratios for
CVS patients versus controls
Variables CVS
(N = 216)
Controls
(N = 142)
P-value
Age in years
(median, range)
34 (25-46) 38.5 (26-53) 0.0111*
Gender <0.0012**
Male 32% (69) 16% (23)
Female 68% (147) 84% (119)
Maternal Ratio 1 0.5 <0.0011**
Paternal Ratio 0.43 0.29 <0.0011**
Matrilineal Inheritance Ratio (MIR) 2.2 1.52 0.0071*
Median values represented for continuous variables.
Numbers after percents are frequencies.
Tests used: 1Wilcoxon test; 2Fisher's exact test.
*Indicates a P value <0.05.
**Indicates a P value < 0.001.
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The prevalence of the various genotypes in haplogroup H
CVS subgroups and historical controls was similar and is
shown in Table 5. Patients with adolescent-onset CVS were
excluded from the analysis as they likely represent an inde-
terminate group.
Further subgroup analysis showed that there were no dif-
ferences in the frequency of 16519 T and 3010A between
pediatric and adult-onset CVS patients. The frequency of
the AT genotype (16519 T and 3010A SNP’s in the same
individual) was also similar in both groups of patients
(Table 5). The frequency of the AT genotype in non H
patients in our cohort was 12% (n = 17) but we are unable
to comment on this as we did not have a non H control
group for comparison.
Discussion
This is the first and largest study to our knowledge in
adults with CVS to determine the presence and degree of
maternal inheritance in adults with CVS in a systematic
manner. A detailed family history was ascertained in both
first and second degree relatives of the index patient. WeFigure 1 Inheritance patterns of functional disorders in adults
with CVS and controls. *P value < 0.001 by Proportional odds
likelihood ratio test between CVS patients and controls.also sought to determine if there were any correlation
between inheritance patterns and mitochondrial DNA
SNP’s 16519 T and 3010A, which have been associated
with increased odds of having CVS in children. The find-
ings of our study reveal that adults with CVS patients have
a higher proportion of probable maternal inheritance of
various functional disorders in comparison to controls
(13% vs 1%, p value <0.0001). There was no association
between maternal inheritance patterns and genotype as
expected. Restricting our analysis to haplogroup H
(71/216, 33%) revealed no significant differences in the
prevalence of 16519 T, 3010A and the AT genotype in
comparison to historical controls. There was also no
difference in the prevalence of these mtDNA SNP’s in
adult and pediatric-onset patients. While this was not
the primary intent of the study, other important findings
in this study include the high percentage of patients (28%)
who underwent surgery for CVS symptoms. This under-
scores the need for prompt diagnosis and appropriate
therapy in this patient population.
Quantitative Pedigree Analysis (QPA) is a novel tool used
for identifying matrilineal inheritance patterns and we
obtained a detailed history of all first and second-degree
relatives of adults with CVS in our cohort using a stand-
ard questionnaire. This revealed that the vast majority
of adults (87%) had a non-maternal inheritance pattern
of functional symptomatology. A small subset of adults
(13%) had a probable maternal inheritance which was
significantly different from controls (13 vs 1%, p < 0.001).
However there was no correlation between the patterns
of inheritance and mtDNA SNP’s 16519 T and 3010A
as expected; this could be explained by the presence of
yet unidentified mitochondrial polymorphisms beyond
the two that were studied. While DNA methylation
may be another possible explanation this would be less
likely and needs to be explored in future studies.
Our genetic analysis of Haplogroup H adults with CVS
(33%, 71) did not show any differences in the frequency of
16519 T, 3010A and the AT genotype between our cohort
and historical controls. We were unable to comment on
Table 4 Inheritance patterns by genotype
Quantitative pedigree analysis GC (N = 100) AC (N = 35) AT (N =18) GT (N = 63) P-value
Maternal Ratio 0.885 1.06 0.835 1 0.3031
Paternal Ratio 0.5 0.345 0.39 0.38 0.7571
Matrilineal Inheritance Ratio 1.81 2.33 2.58 2.75 0.2181
Inheritance pattern 0.2172
PNMI 85% (79) 70% (24) 81% (13) 75% (40)
Ind 7% (6) 15% (5) 0% (0) 8% (4)
PMI 8% (7) 15% (5) 19% (3) 17% (9)
Median values represented for continuous variables.
Numbers after percents are frequencies.
Tests used: 1Wilcoxon test; 2Proportional odds likelihood ratio test.
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population readily available for comparison. Age of onset
was also not a determinant of the presence of the mtDNA
SNP’s as reported in a previous study. The study by
McCallum et al. revealed that pediatric onset CVS patients
were more likely to have 16519 T and the AT genotype.
One possible explanation for these differences between
our study and the previous one may be due to the fact
that most of the childhood onset patients in the above
mentioned study were recruited through a genetic clinic
which may have resulted in a referral bias. Twelve % (17)
of patients in the non H group had the AT genotype
but the significance of these results is unclear with this
present study. Most of the studies in CVS have been
performed in Haplogroup H patients as they are genet-
ically homogenous.
A recent study by Camilleri et al. examined the frequency
of irritable bowel syndrome (IBS) in both Haplogroup H
and non- H patients. This interesting study revealed that
the IBS –C and IBS with alternating constipation and diar-
rhea was more prevalent in non H individuals. In this same
study, Haplogroup H individuals had higher maximal toler-
ated volumes (lower satiety) and 3010A in these individualsTable 5 Odds ratios with 95% CI comparing the prevalence o
historical controls
Outcome Comparison Estim
16519 T vs. C Pediatric vs. Control 2.33
16519 T vs. C Adult vs. Control 1.16
16519 T vs. C Adult vs. Pediatric 0.50
3010 A vs. G Pediatric vs. Control 0.53
3010 A vs. G Adult vs. Control 1.09
3010 A vs. G Adult vs. Pediatric 2.05
AT vs. non-AT Pediatric vs. Control 0.00
AT vs. non-AT Adult vs. Control 4.18
AT vs. non-AT Adult vs. Pediatric Inf
The type I error rate was controlled at 5% using a single-step multiple testing adjus
regression model.was associated with abdominal pain/dyspepsia and more
rapid emptying [13]. The frequency of the AT genotype
in this non H group was not readily available but future
collaborative studies pooling such data would serve to
make more meaningful comparisons.
The strengths of our study are that this represents a
large sample of adults with CVS with extensive clinical
information obtained prospectively. Pedigree analysis was
conducted using a standard script, ensuring uniformity in
data collection. Limitations include the possibility of recall
bias when obtaining family histories and that most of the
information was usually gleaned from the patients and
their mothers, which may have led to missing information
on the paternal side. However, every effort was made to
address this and patients were called on multiple occa-
sions if necessary to clarify the family history. However,
the same limitations apply to the control group as well
and are unlikely to have influenced overall results. Other
limitations include the lack of a gold standard for diagnos-
ing CVS as with other functional disorders. While this
was a large heterogeneous group of CVS patients, we
cannot exclude a referral bias with sicker patients being
included. Arguably these are the very patients who wouldf a genotype between haplotype H CVS subgroups and
ate Confidence interval (CI) P-value
(0.54 – 10.07) 0.74
(0.48 – 2.82) 1
(0.10 – 2.50) 1
(0.09 – 3.18) 1
(0.46 – 2.56) 1
(0.30 – 13.85) 1
(0.00 – Inf) 1
(0.10 – 177.81) 1
(0.00 – Inf) 1
tment based on the multivariate normal distribution in the context of a logistic
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mechanisms underlying CVS would be even more import-
ant with this population. Other considerations are that we
chose to include only haplogroup H patients for genotype
comparison with controls as non-H control data was not
readily available. Given the changing demographics of the
US population, future studies should be extended to
include both groups of patients. The presence of a high
degree of matrilineal inheritance of functional disorders
was not associated with a specific genotype as expected
and may be due to yet unidentified mtDNA sequences.
Other factors beyond the mtDNA sequence, possibly
including nuclear-encoded mitochondrial genes, other
genes, and the environment may play a larger role in the
pathophysiology of CVS in adults as opposed to children.Conclusions
Our study demonstrates that CVS in a subset of adults is
associated with a maternal inheritance pattern of functional
GI disorders as seen in children but is not associated with
16519 T, 3010 A or the AT genotype. A matrilineal inherit-
ance pattern was higher in pediatric onset CVS compared
to adult onset CVS. However, onset of disease did not
have any correlation with the frequency of the mtDNA
SNP’s. While this study offers some insight into the
genetic background of CVS, further studies examining
the entire mtDNA, as well as the full mitochondrial exome
(the full mtDNA sequence plus nuclear genes encoding
mitochondrial proteins) are warranted.Additional file
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